To achieve this goal, we developed silica nanoparticles conjugated with hyaluronic acid (HA) and folic acid (FA), shown in Figure 1, to target the Cluster of Differentiation 44 (CD44) and folate receptors, respectively, using a colon cancer model. The gene discussed is CD44; the disease is colonic neoplasm.